For: | Kumar A, Gautam V, Sandhu A, Rawat K, Sharma A, Saha L. Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review. World J Gastrointest Surg 2023; 15(4): 495-519 [PMID: PMC10190721 DOI: 10.4240/wjgs.v15.i4.495] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i4/495.htm |
Number | Citing Articles |
1 |
Alexandra Razumovskaya, Mariia Silkina, Andrey Poloznikov, Timur Kulagin, Maria Raigorodskaya, Nina Gorban, Anna Kudryavtseva, Maria Fedorova, Boris Alekseev, Alexander Tonevitsky, Sergey Nikulin. Predicting patient outcomes with gene-expression biomarkers from colorectal cancer organoids and cell lines. Frontiers in Molecular Biosciences 2025; 12 doi: 10.3389/fmolb.2025.1531175
|
2 |
Purvish M Parikh, Tarini P. Sahoo, Ghanashyam Biswas, Vineet Talwar, Somashekhar SP, Soumya Surath Panda, Avinash CB, Nishita Shetty, Anita Ramesh, Joydeep Ghosh, Vijith Vital Shetty, Radheshyam Naik, Ashish Singh, Gaurav Gupta, Bhavesh Parekh. Practical Consensus Guidelines for the Use of S-1 in GI Malignancies. South Asian Journal of Cancer 2024; 13(01): 077 doi: 10.1055/s-0043-1778685
|
3 |
Muthusamy Thangavel, Chalini Vijayakumar , Deepalakkshmi Balakrishnan. Circular RNAs: Therapeutic Uses in Colorectal Cancer. International Journal of Experimental Research and Review 2024; 45(Spl Vol): 274 doi: 10.52756/ijerr.2024.v45spl.022
|
4 |
Ajnas Alkatheeri, Suliman Salih, Noon Kamil, Sara Alnuaimi, Memona Abuzar, Shahd Shehadeh Abdelrahman. Nano-Radiopharmaceuticals in Colon Cancer: Current Applications, Challenges, and Future Directions. Pharmaceuticals 2025; 18(2): 257 doi: 10.3390/ph18020257
|
5 |
Taha I. Huda, Diep Nguyen, Arpan Sahoo, Joanna J. Song, Alexander F. Gutierrez, Boris I. Chobrutskiy, George Blanck. Adaptive Immune Receptor Distinctions Along the Colorectal Polyp-Tumor Timelapse. Clinical Colorectal Cancer 2024; 23(4): 402 doi: 10.1016/j.clcc.2024.07.002
|
6 |
Barbara A Abreu Lopez, Rafael Pinto-Colmenarez, Fides Myles C Caliwag, Lorraine Ponce-Lujan, Mariela D Fermin, Ana V Granillo Cortés, Anette G Mejía Martínez, Ismael G Zepeda Martinez, Fernanda Gress León. Colorectal Cancer Screening and Management in Low- and Middle-Income Countries and High-Income Countries: A Narrative Review. Cureus 2024; doi: 10.7759/cureus.70933
|
7 |
Maguie El Boustani, Nayla Mouawad, Monah Abou Alezz. AP3M2: A key regulator from the nervous system modulates autophagy in colorectal cancer. Tissue and Cell 2024; 91: 102593 doi: 10.1016/j.tice.2024.102593
|
8 |
Lloyd Mabonga, Rebecca Leony Fourie, Abidemi Paul Kappo, Sylvester Lyantagaye, Zodwa Dlamini. Colorectal Cancer Treatment Resistance. 2025; : 107 doi: 10.1016/B978-0-443-33475-7.00001-9
|
9 |
Hendra Susanto, Sa'diyatul Rizqie Amaliyah Firdaus, Moch Sholeh, Agustina Tri Endharti, Ahmad Taufiq, Nik Ahmad Nizam Nik Malek, Happy Kurnia Permatasari. Moringa oleifera Leaf Powder – Silver Nanoparticles (MOLP-AgNPs) efficiently inhibit metastasis and proliferative signaling in HT-29 human colorectal cancer cells. Journal of Agriculture and Food Research 2024; 16: 101149 doi: 10.1016/j.jafr.2024.101149
|
10 |
Otilia Menyhart, János Tibor Fekete, Balázs Győrffy. Inflammation and Colorectal Cancer: A Meta-Analysis of the Prognostic Significance of the Systemic Immune–Inflammation Index (SII) and the Systemic Inflammation Response Index (SIRI). International Journal of Molecular Sciences 2024; 25(15): 8441 doi: 10.3390/ijms25158441
|
11 |
Cesar Augusto Sobrinho, Alexandre Moreira de Almeida, Maytana Roberta Taschin Grigolo, Michele Selzler, Antônio Carlos de Abreu, Letícia Silva Fagundes, Almir Souza Martins, Durval Batista Palhares, Rondon Tosta Ramalho. Unfolded protein response during the progression of colorectal carcinogenesis. Acta Cirúrgica Brasileira 2025; 40 doi: 10.1590/acb400725
|
12 |
Pengju Yao, Mingjie Gao, Weiyi Hu, Jiahao Wang, Yuhao Wang, Qingsong Wang, Jianguo Ji. Proteogenomic analysis identifies neoantigens and bacterial peptides as immunotherapy targets in colorectal cancer. Pharmacological Research 2024; 204: 107209 doi: 10.1016/j.phrs.2024.107209
|
13 |
Ju-Hee Park, Yu-Na Hwang, Han-Heom Na, Do-Yeon Kim, Hyo-Jun Lee, Tae-Hyung Kwon, Jin-Sung Park, Keun-Cheol Kim. Cannabigerol Treatment Shows Antiproliferative Activity and Causes Apoptosis of Human Colorectal Cancer Cells. Journal of Pharmacopuncture 2024; 27(4): 332 doi: 10.3831/KPI.2024.27.4.332
|
14 |
Federica Randisi, Gianpaolo Perletti, Emanuela Marras, Marzia Bruna Gariboldi. Green Tea Components: In Vitro and In Vivo Evidence for Their Anticancer Potential in Colon Cancer. Cancers 2025; 17(4): 623 doi: 10.3390/cancers17040623
|
15 |
Ghada Ayeldeen, Bahaa Badr, Olfat Shaker, Khaled Diab, Tarek Ahmed, Essam Hassan, Raghda Nagaty, Shaymaa Galal, Nabil Hasona. Integrated analysis of non‑coding RNAs (HOTAIR and miR‑130a) and their cross‑talk with TGF‑β1, SIRT1 and E‑cadherin as potential biomarkers in colorectal cancer. Oncology Letters 2025; 29(3) doi: 10.3892/ol.2025.14863
|
16 |
涵静 丁. Recent Advancements on the Anti-Tumor Small Molecule Inhibitors Targeting the p53-MDM2 Interaction. Advances in Clinical Medicine 2023; 13(08): 13474 doi: 10.12677/ACM.2023.1381881
|
17 |
Huwei Nie, Jie Zhang, Yang Ai, Ailin Chen, Yuxi Li, Lin Zhang. Development and validation of prognostic nomograms for overall survival in patients with locally advanced colorectal cancer. Alexandria Engineering Journal 2024; 87: 308 doi: 10.1016/j.aej.2023.12.040
|
18 |
Riley M. Whalen, Ashley N. Anderson, Jocelyn A. Jones, Zachary Sims, Young Hwan Chang, Michel A. Nederlof, Melissa H. Wong, Summer L. Gibbs. Ultra high content analyses of circulating and tumor associated hybrid cells reveal phenotypic heterogeneity. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-57381-8
|
19 |
Luis A. Arteaga-Blanco, Andrew E. Evans, Dan A. Dixon. Plasma-Derived Extracellular Vesicles and Non-Extracellular Vesicle Components from APCMin/+ Mice Promote Pro-Tumorigenic Activities and Activate Human Colonic Fibroblasts via the NF-κB Signaling Pathway. Cells 2024; 13(14): 1195 doi: 10.3390/cells13141195
|
20 |
Yiping Zhang, Jun Xie. Targeting ferroptosis regulators by natural products in colorectal cancer. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1374722
|
21 |
Sara Assi, Berthe Hayar, Claudio Pisano, Nadine Darwiche, Walid Saad. Novel ST1926 Nanoparticle Drug Formulation Enhances Drug Therapeutic Efficiency in Colorectal Cancer Xenografted Mice. Nanomaterials 2024; 14(17): 1380 doi: 10.3390/nano14171380
|
22 |
Samuele Tardito, Serena Matis, Maria Raffaella Zocchi, Roberto Benelli, Alessandro Poggi. Epidermal Growth Factor Receptor Targeting in Colorectal Carcinoma: Antibodies and Patient-Derived Organoids as a Smart Model to Study Therapy Resistance. International Journal of Molecular Sciences 2024; 25(13): 7131 doi: 10.3390/ijms25137131
|
23 |
Marcel Madej, Celina Kruszniewska-Rajs, Magdalena Kimsa-Dudek, Agnieszka Synowiec-Wojtarowicz, Elwira Chrobak, Ewa Bębenek, Stanisław Boryczka, Stanisław Głuszek, Jolanta Adamska, Sebastian Kubica, Jarosław Matykiewicz, Joanna Magdalena Gola. The Influence of Betulin and Its Derivatives on Selected Colorectal Cancer Cell Lines’ Viability and Their Antioxidant Systems. Cells 2024; 13(16): 1368 doi: 10.3390/cells13161368
|
24 |
Ashkan Bahrami, Amirreza Khalaji, Majed Bahri Najafi, Sina Sadati, Arash Raisi, AmirMohammad Abolhassani, Reza Eshraghi, Mahmood Khaksary Mahabady, Neda Rahimian, Hamed Mirzaei. NF-κB pathway and angiogenesis: insights into colorectal cancer development and therapeutic targets. European Journal of Medical Research 2024; 29(1) doi: 10.1186/s40001-024-02168-w
|
25 |
Francesco Gervasi, Fanny Pojero. Use of Oleuropein and Hydroxytyrosol for Cancer Prevention and Treatment: Considerations about How Bioavailability and Metabolism Impact Their Adoption in Clinical Routine. Biomedicines 2024; 12(3): 502 doi: 10.3390/biomedicines12030502
|
26 |
Nikola Radenković, Danijela Nikodijević, Jovana Jovankić, Stefan Blagojević, Milena Milutinović. Resistance to 5-fluorouracil: The molecular mechanisms of development in colon cancer cells. European Journal of Pharmacology 2024; 983: 176979 doi: 10.1016/j.ejphar.2024.176979
|
27 |
Abdo Meyiah, Faez Iqbal Khan, Dia Aldeen Alfaki, Khaled Murshed, Afsheen Raza, Eyad Elkord. The colorectal cancer microenvironment: Preclinical progress in identifying targets for cancer therapy. Translational Oncology 2025; 53: 102307 doi: 10.1016/j.tranon.2025.102307
|
28 |
Joanna Słoka, Barbara Strzałka-Mrozik, Sebastian Kubica, Ilona Nowak, Celina Kruszniewska-Rajs. Influence of Mesalazine on Ferroptosis-Related Gene Expression in In Vitro Colorectal Cancer Culture. Biomedicines 2025; 13(1): 219 doi: 10.3390/biomedicines13010219
|
29 |
Duogang Xu, Yulei He, Changkang Liao, Jing Tan. Combining KRAS gene status with preoperative D‑dimer levels as a predictive marker of venous thromboembolism risk in patients with resectable colorectal cancer: A prospective cohort study. Biomedical Reports 2024; 20(6) doi: 10.3892/br.2024.1784
|
30 |
Shiliang Cheng, Meng Li, Chunguang Li, Yonggang Dai, Jinhua Zhuo, Jue Wang, Jingrong Qian, Zhihao Hao. JAML inhibits colorectal carcinogenesis by modulating the tumor immune microenvironment. In Vitro Cellular & Developmental Biology - Animal 2024; 60(4): 382 doi: 10.1007/s11626-024-00881-8
|
31 |
Jing‐Ru Weng, Chih‐Wen Shu, Chia‐Che Chang, Ya‐Chun Wu, Hsiu‐Chen Yang, Cheng‐Hsin Lee, Hans‐Uwe Dahms, Wei‐Yu Lin, Chun‐Lin Chen, Pei‐Feng Liu. Aglaia elliptifolia Leaf Extract Inhibits Autophagy‐Related 4B Protease and Suppresses Malignancies of Colorectal Cancer Cells. Environmental Toxicology 2024; doi: 10.1002/tox.24439
|
32 |
Chiugo Okoye, My Tran, Elizabeth Soladoye, Darlington E Akahara, Chinemerem M Emeasoba, Blessing T Ojinna, Emmanuel Anasonye, Oyindamola O Obadare, Chiamaka S Diala, Bolanle H Salaudeen, Endurance O Evbayekha, Okelue E Okobi. A Review of 10-Year Survivability of Immunotherapy in the Management of Colon Cancer. Cureus 2023; doi: 10.7759/cureus.43189
|
33 |
Sezgin Zeren, Semih Seker, Gizem Akkaş Akgün, Emrah Okur, Azmi Yerlikaya. Label-free nLC-MS/MS proteomic analysis reveals significant differences in the proteome between colorectal cancer tissues and normal colon mucosa. Medical Oncology 2023; 40(10) doi: 10.1007/s12032-023-02173-9
|
34 |
Jae Yeon Choi, Hyun Jeong Seok, Dong Hyeon Lee, Junhye Kwon, Ui Sup Shin, Incheol Shin, In Hwa Bae. miR-1226-5p is involved in radioresistance of colorectal cancer by activating M2 macrophages through suppressing IRF1. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05797-1
|
35 |
Claudia C. Wahoski, Bhuminder Singh. The Roles of RAC1 and RAC1B in Colorectal Cancer and Their Potential Contribution to Cetuximab Resistance. Cancers 2024; 16(13): 2472 doi: 10.3390/cancers16132472
|
36 |
Mariana Melo Moreira, Marta Carriço, Manuel Luís Capelas, Nuno Pimenta, Teresa Santos, Susana Ganhão-Arranhado, Antti Mäkitie, Paula Ravasco. The impact of pre-, pro- and synbiotics supplementation in colorectal cancer treatment: a systematic review. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1395966
|
37 |
Mary Garvey. Intestinal Dysbiosis: Microbial Imbalance Impacts on Colorectal Cancer Initiation, Progression and Disease Mitigation. Biomedicines 2024; 12(4): 740 doi: 10.3390/biomedicines12040740
|
38 |
Anil Kumar, Lekha Saha. Colorectal cancer cell dormancy: An insight into pathways. World Journal of Gastroenterology 2024; 30(33): 3810-3817 doi: 10.3748/wjg.v30.i33.3810
|
39 |
Alessandra Verdina, Alessia Garufi, Valerio D’Orazi, Gabriella D’Orazi. HIPK2 in Colon Cancer: A Potential Biomarker for Tumor Progression and Response to Therapies. International Journal of Molecular Sciences 2024; 25(14): 7678 doi: 10.3390/ijms25147678
|
40 |
Taxiarchis Konstantinos Nikolouzakis, Emmanuel Chrysos, Anca Oana Docea, Persefoni Fragkiadaki, John Souglakos, John Tsiaoussis, Aristidis Tsatsakis. Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy. Cancers 2024; 16(11): 1995 doi: 10.3390/cancers16111995
|
41 |
Pablo Garrido, Adrián Casas-Benito, Ignacio M. Larrayoz, Judit Narro-Íñiguez, Susana Rubio-Mediavilla, Enrique Zozaya, Alfonso Martín-Carnicero, Alfredo Martínez. Expression of Mitochondrial Long Non-Coding RNAs, MDL1 and MDL1AS, Are Good Prognostic and/or Diagnostic Biomarkers for Several Cancers, Including Colorectal Cancer. Cancers 2024; 16(5): 960 doi: 10.3390/cancers16050960
|
42 |
Babak Arjmand, Sepideh Alavi-Moghadam, Zahra Faraji, Morteza Aghajanpoor-Pasha, Hasan Jalaeikhoo, Mohsen Rajaeinejad, Mohsen Nikandish, Ali Faridfar, Ahmad Rezazadeh-Mafi, Mostafa Rezaei-Tavirani, Arsalan Irompour. Cell Biology and Translational Medicine, Volume 22. Advances in Experimental Medicine and Biology 2024; 1470: 115 doi: 10.1007/5584_2024_803
|
43 |
Leila Dadgar-Zankbar, Zahra Elahi, Aref Shariati, Azad Khaledi, Shabnam Razavi, Amin Khoshbayan. Exploring the role of Fusobacterium nucleatum in colorectal cancer: implications for tumor proliferation and chemoresistance. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-024-01909-y
|
44 |
RAMADEVI PEMMEREDDY, AJAY MILI, BHARATH HAROHALLI BYREGOWDA, JYOTHI GIRIDHAR, SREEDHARA RANGANATH PAI K, ANNA MATHEW, VASUDEV PAI, CHANDRASHEKAR K. S. NETWORK PHARMACOLOGY BASED COMPUTATIONAL STUDY TO INVESTIGATE THE POTENTIAL MECHANISM OF SYZYGIUM CARYOPHYLLATUM AGAINST COLON CANCER. International Journal of Applied Pharmaceutics 2025; : 161 doi: 10.22159/ijap.2025v17i1.52490
|
45 |
Soukaina Benmokhtar, Abdelilah Laraqui, Farida Hilali, Tahar Bajjou, Sara El Zaitouni, Meryem Jafari, Walid Baba, Hicham Elannaz, Idriss Amine Lahlou, Chahdi Hafsa, Mohamed Oukabli, Tarik Mahfoud, Rachid Tanz, Mohamed Ichou, Khaled Ennibi, Nadia Dakka, Yassine Sekhsokh. RAS/RAF/MAPK Pathway Mutations as Predictive Biomarkers in Middle Eastern Colorectal Cancer: A Systematic Review. Clinical Medicine Insights: Oncology 2024; 18 doi: 10.1177/11795549241255651
|
46 |
Ivana Večurkovská, Marek Stupák, Jana Kaťuchová, Peter Bohuš, Lenka Hostačná, Mária Mareková, Jana Mašlanková. Expression of individual members of the TGF-β/SMAD signalling pathway in the progression and survival of patients with colorectal carcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-79463-3
|
47 |
Fatemeh B. Rassouli, Maryam M. Matin, Farzin Hadizadeh, Masoud Nejabat, Hossein Allahverdizadeh, Hamidreza Jamali, Shahin Gharedaghi, Halimeh Hassanzadeh. Exploring the anti-metastatic potential of sunitinib and novel analogs in colorectal cancer: insights into HIF-1α mediated metastasis. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1520881
|
48 |
Marlene Schwarzfischer, Maria Rae Walker, Michele Curcio, Nader M. Boshta, Arnaud Marchand, Erik Soons, Doris Pöhlmann, Marcin Wawrzyniak, Yasser Morsy, Silvia Lang, Marianne Rebecca Spalinger, Matthias Versele, Michael Scharl. Synthetic GPR84 Agonists in Colorectal Cancer: Effective in THP-1 Cells but Ineffective in BMDMs and MC38 Mouse Tumor Models. International Journal of Molecular Sciences 2025; 26(2): 490 doi: 10.3390/ijms26020490
|
49 |
Dawid Przystupski, Dagmara Baczyńska, Joanna Rossowska, Julita Kulbacka, Marek Ussowicz. Calcium ion delivery by microbubble-assisted sonoporation stimulates cell death in human gastrointestinal cancer cells. Biomedicine & Pharmacotherapy 2024; 179: 117339 doi: 10.1016/j.biopha.2024.117339
|
50 |
Anil Kumar, Bakr Ahmed, Indu Pal Kaur, Lekha Saha. Exploring dose and downregulation dynamics in lipid nanoparticles based siRNA therapy: Systematic review and meta-analysis. International Journal of Biological Macromolecules 2024; 277: 133984 doi: 10.1016/j.ijbiomac.2024.133984
|
51 |
Ursheeta Singh, Rekha Rani Kokkanti, Srinivas Patnaik. Beyond chemotherapy: Exploring 5-FU resistance and stemness in colorectal cancer. European Journal of Pharmacology 2025; 991: 177294 doi: 10.1016/j.ejphar.2025.177294
|
52 |
Agata Binienda, Weronika Machelak, Marta Zielińska, Jakub Fichna. Free fatty acid receptors type 2 and 4 mediate the anticancer effects of fatty acids in colorectal cancer - in vitro and in vivo studies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2025; 1871(4): 167708 doi: 10.1016/j.bbadis.2025.167708
|
53 |
Faris Alrumaihi. Exploring the Chemopreventive Potential of Artemisia annua Methanolic Extract in Colorectal Cancer Induced by Azoxymethane in Mice. Pharmaceuticals 2024; 18(1): 34 doi: 10.3390/ph18010034
|
54 |
Sourik Mukherjee, Dharmender Kumar, Dipanjan Guha. Insights of probiotics as an alternative medicine for cancer therapy, mechanism, and applications. Medicine in Microecology 2024; 22: 100111 doi: 10.1016/j.medmic.2024.100111
|
55 |
Krunal Pawar, Pramodkumar P. Gupta, Pooran Singh Solanki, Ravi Ranjan Kumar Niraj, Shanker L. Kothari. Targeting SLC4A4: A Novel Approach in Colorectal Cancer Drug Repurposing. Current Issues in Molecular Biology 2025; 47(1): 67 doi: 10.3390/cimb47010067
|
56 |
Anil Kumar, Nikhil Aravind, Tayiba Gillani, Deepak Kumar. Artificial intelligence breakthrough in diagnosis, treatment, and prevention of colorectal cancer – A comprehensive review. Biomedical Signal Processing and Control 2025; 101: 107205 doi: 10.1016/j.bspc.2024.107205
|
57 |
Afza Ahmad, Rohit Kumar Tiwari, Saleha Siddiqui, Muskan Chadha, Ratnakar Shukla, Vivek Srivastava. Targeting Signaling Pathways in Solid Tumors - Part A. International Review of Cell and Molecular Biology 2024; 385: 41 doi: 10.1016/bs.ircmb.2023.11.006
|
58 |
Michael Giarrizzo, Joseph F. LaComb, Hetvi R. Patel, Rohan G. Reddy, John D. Haley, Lee M. Graves, Edwin J. Iwanowicz, Agnieszka B. Bialkowska. TR-107, an Agonist of Caseinolytic Peptidase Proteolytic Subunit, Disrupts Mitochondrial Metabolism and Inhibits the Growth of Human Colorectal Cancer Cells. Molecular Cancer Therapeutics 2024; 23(12): 1761 doi: 10.1158/1535-7163.MCT-24-0170
|
59 |
Simona Gabriela Duta-Ion, Ioana Ruxandra Juganaru, Iulian Andrei Hotinceanu, Andra Dan, Livia Malina Burtavel, Madalin Codrut Coman, Ina Ofelia Focsa, Andra Giorgiana Zaruha, Patricia Christina Codreanu, Laurentiu Camil Bohiltea, Viorica Elena Radoi. Redefining Therapeutic Approaches in Colorectal Cancer: Targeting Molecular Pathways and Overcoming Resistance. International Journal of Molecular Sciences 2024; 25(23): 12507 doi: 10.3390/ijms252312507
|
60 |
Lena Van Dingenen, Charlotte Segers, Shari Wouters, Mohamed Mysara, Natalie Leys, Samir Kumar-Singh, Surbhi Malhotra-Kumar, Rob Van Houdt. Dissecting the role of the gut microbiome and fecal microbiota transplantation in radio- and immunotherapy treatment of colorectal cancer. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1298264
|
61 |
Hiba Fadlallah, Jad El Masri, Hiam Fakhereddine, Joe Youssef, Chrystelle Chemaly, Samer Doughan, Wassim Abou-Kheir. Colorectal cancer: Recent advances in management and treatment. World Journal of Clinical Oncology 2024; 15(9): 1136-1156 doi: 10.5306/wjco.v15.i9.1136
|
62 |
Sushma S. Kumar, Ashna Fathima, Preeti Srihari, Trinath Jamma. Host-gut microbiota derived secondary metabolite mediated regulation of Wnt/β-catenin pathway: a potential therapeutic axis in IBD and CRC. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1392565
|
63 |
Bin Jiang, Hongjian Zhou, Xingwang Xie, Tian Xia, Chao Ke. Down-regulation of zinc finger protein 335 undermines natural killer cell function in mouse colitis-associated colorectal carcinoma. Heliyon 2024; 10(4): e25721 doi: 10.1016/j.heliyon.2024.e25721
|
64 |
Guillermo Valenzuela, Héctor R. Contreras, Katherine Marcelain, Mauricio Burotto, Jaime González-Montero. Understanding microRNA-Mediated Chemoresistance in Colorectal Cancer Treatment. International Journal of Molecular Sciences 2025; 26(3): 1168 doi: 10.3390/ijms26031168
|
65 |
Christian Kenneth, Rudi Nirwantono, Bens Pardamean. Bioinformatics exploration into potential mechanisms of Calamus draco for colorectal cancer treatment. Procedia Computer Science 2024; 245: 127 doi: 10.1016/j.procs.2024.10.236
|
66 |
Ya-Chu Tang, Jing-Jim Ou, Shu-Ching Hsu, Chih-Hsiang Huang, Li-Mei Lin, Hsin-Huei Chang, Yi-Hsin Wang, Zih-Ting Huang, Manwu Sun, Ko-Jiunn Liu, Yi-Mei Hung, Chi-Yun Lai, Chuan Shih, Chiung-Tong Chen, Jang-Yang Chang, Hsing-Pang Hsieh, Weir-Torn Jiaang, Ching-Chuan Kuo. Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models. Pharmacological Research 2025; 211: 107556 doi: 10.1016/j.phrs.2024.107556
|
67 |
Aisha Shigna Nadukkandy, Britny Blaize, Chethana D Kumar, Giulia Mori, Marco Cordani, Lekha Dinesh Kumar. Non-coding RNAs as mediators of epithelial to mesenchymal transition in metastatic colorectal cancers. Cellular Signalling 2025; 127: 111605 doi: 10.1016/j.cellsig.2025.111605
|
68 |
Marcel Madej, Joanna Gola, Elwira Chrobak. Synthesis, Pharmacological Properties, and Potential Molecular Mechanisms of Antitumor Activity of Betulin and Its Derivatives in Gastrointestinal Cancers. Pharmaceutics 2023; 15(12): 2768 doi: 10.3390/pharmaceutics15122768
|
69 |
Sayan Saha, Shreya Ghosh, Suman Ghosh, Sumit Nandi, Aditi Nayak. Unraveling the complexities of colorectal cancer and its promising therapies – An updated review. International Immunopharmacology 2024; 143: 113325 doi: 10.1016/j.intimp.2024.113325
|
70 |
Maxim Girod, Anja Geisler, Luisa Hinze, Leslie Elsner, Babette Dieringer, Antje Beling, Jens Kurreck, Henry Fechner. Combination of FOLFOXIRI Drugs with Oncolytic Coxsackie B3 Virus PD-H Synergistically Induces Oncolysis in the Refractory Colorectal Cancer Cell Line Colo320. International Journal of Molecular Sciences 2024; 25(11): 5618 doi: 10.3390/ijms25115618
|
71 |
Irene Palenca, Silvia Basili Franzin, Aurora Zilli, Luisa Seguella, Anna Troiani, Federico Pepi, Martina Vincenzi, Giuseppe Giugliano, Viviana Catapano, Italia Di Filippo, Giovanni Sarnelli, Giuseppe Esposito. N‐palmitoyl‐d‐glucosamine limits mucosal damage and VEGF‐mediated angiogenesis by PPARα‐dependent suppression of pAkt/mTOR/HIF1α pathway and increase in PEA levels in AOM/DSS colorectal carcinoma in mice. Phytotherapy Research 2024; 38(11): 5350 doi: 10.1002/ptr.8303
|
72 |
Ashok Kumar, Anirudh Goyal. Emerging molecules, tools, technology, and future of surgical knife in gastroenterology. World Journal of Gastrointestinal Surgery 2024; 16(4): 988-998 doi: 10.4240/wjgs.v16.i4.988
|
73 |
Lucian Flavius Herlo, Ioana Golu, Alexandra Herlo, Claudia Raluca Balasa Virzob, Ionescu Alin, Stela Iurciuc, Ionut Eduard Iordache, Luana Alexandrescu, Doina Ecaterina Tofolean, Raluca Dumache. Impact of Preoperative and Intraoperative Factors on Postoperative Outcomes in Patients with Colorectal Cancer: A 10-Year Retrospective Study. Diseases 2025; 13(1): 16 doi: 10.3390/diseases13010016
|
74 |
Raza M. Mirza, Sabrin Salim, Jennifer A. H. Bell, Mary Jane Esplen, Karen V. MacDonald, Barry D. Stein, Deborah A. Marshall. Exploring How Values of Colorectal Cancer Patients and their Caregivers Influence Treatment Decision-Making. The Patient - Patient-Centered Outcomes Research 2024; doi: 10.1007/s40271-024-00716-4
|
75 |
Or Michaeli, Ishai Luz, Maayan Vatarescu, Tal Manko, Noam Weizman, Yevgeniya Korotinsky, Alexandra Tsitrina, Alex Braiman, Lior Arazi, Tomer Cooks. APR-246 as a radiosensitization strategy for mutant p53 cancers treated with alpha-particles-based radiotherapy. Cell Death & Disease 2024; 15(6) doi: 10.1038/s41419-024-06830-3
|
76 |
Chunxiao Song, Chunwu Zhao. Innovative Bacterial Therapies and Genetic Engineering Approaches in Colorectal Cancer: A Review of Emerging Strategies and Clinical Implications. Journal of Microbiology and Biotechnology 2024; 34(12): 2397 doi: 10.4014/jmb.2408.08026
|
77 |
Botle Precious Damane, Thanyani Mulaudzi, Odisang Daniel Montwedi, Peace Mabeta, Shakeel Kader, William Leenders, Zodwa Dlamini. Colorectal Cancer Treatment Resistance. 2025; : 147 doi: 10.1016/B978-0-443-33475-7.00013-5
|